Laparoscopic Ileal Interposition Associated to a Diverted Sleeve Gastrectomy is an Effective Operation for the Treatment of Type 2 Diabetes Mellitus Patients with BMI 21-29
Overview
General Surgery
Radiology
Authors
Affiliations
Background: The objective of this study is to evaluate the clinical results of the laparoscopic interposition of a segment of ileum into the proximal duodenum associated to a sleeve gastrectomy (II-DSG) in order to treat patients with type 2 diabetes mellitus (T2DM) and body mass index (BMI) 21-29 kg/m2.
Patients And Methods: The laparoscopic procedure was performed in 69 patients, 22 female and 47 male. Mean age was 51 years (range 41-63 years). Mean BMI was 25.7 (21.8-29.2) kg/m2. All patients had the diagnosis of T2DM for at least 3 years and evidence of stable treatment with oral hypoglycemic agents and or insulin for at least 12 months. Insulin therapy was used by 44% of the patients. Mean duration of T2DM was 11 years (range 3-18 years). Dyslipidemia was diagnosed in 72.5% and hypertension in 66.7%. Nephropathy was characterized in 29% of the patients, retinopathy in 26.1%, and neuropathy in 24.6%.
Results: Overall, 95.7% of the patients achieved adequate glycemic control (Hb(A1c) < 7%) without antidiabetic medication. Hb(A1c) below 6% was achieved by 65.2%. Mean postoperative follow-up was 21.7 months (range 7-42 months). Mean postoperative BMI was 21.8 kg/m2. There was no conversion to open surgery. Median hospital stay was 3.4 days (range 2-58 days). Major postoperative complications were diagnosed in 7.3%. There was no mortality. Fasting glycemia decreased from a mean of 218 to 102 mg/dl, postprandial glycemia from 305 to 141 mg/dl, and homeostasis model assessment of insulin resistance (Homa-IR) from 5.2 to 0.77. All associated comorbidities and complications related to T2DM had significant improvement or control. Arterial hypertension was controlled in 91.3%. Macroalbuminuria was no longer observed. Microalbuminuria resolved in 87.5% of patients. Hypercholesterolemia was normalized in 95% and hypertriglyceridemia in 92% of patients.
Conclusions: Laparoscopic II-DSG was an effective operation in controlling T2DM in a nonobese (BM < 30 kg/m2) population. Associated diseases and related complications were also improved. A longer follow-up period is needed.
Bariatric surgery and diabetes: Current challenges and perspectives.
He Y, Hu X, Liu J, Li H, Lu S World J Diabetes. 2024; 15(8):1692-1703.
PMID: 39192861 PMC: 11346089. DOI: 10.4239/wjd.v15.i8.1692.
Innovative Bariatric Procedures and Ethics in Bariatric Surgery: the IFSO Position Statement.
Haddad A, Kow L, Herrera M, Cohen R, Himpens J, Greve J Obes Surg. 2022; 32(10):3217-3230.
PMID: 35922610 DOI: 10.1007/s11695-022-06220-8.
Improvement of Renal Function After Bariatric Surgery: a Systematic Review and Meta-analysis.
Huang H, Lu J, Dai X, Li Z, Zhu L, Zhu S Obes Surg. 2021; 31(10):4470-4484.
PMID: 34355340 DOI: 10.1007/s11695-021-05630-4.
Technical Feasibility of a Murine Model of Sleeve Gastrectomy with Ileal Transposition.
Ying L, Breuer G, Hubbard M, Nadzam G, Hwa J, Martin K Obes Surg. 2018; 29(2):593-600.
PMID: 30353248 PMC: 6365182. DOI: 10.1007/s11695-018-3555-7.
Foschi D, Sorrentino L, Tubazio I, Vecchio C, Vago T, Bevilacqua M Surg Endosc. 2018; 33(5):1553-1563.
PMID: 30225603 DOI: 10.1007/s00464-018-6443-2.